Scott L Kominsky Selected Research

Ductal Carcinoma

4/2003

Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Scott L Kominsky Research Topics

Disease

10	Neoplasms (Cancer) 01/2018 - 01/2006
10	Breast Neoplasms (Breast Cancer) 01/2018 - 04/2003
8	Neoplasm Metastasis (Metastasis) 01/2016 - 05/2004
4	Renal Cell Carcinoma (Grawitz Tumor) 03/2008 - 01/2007
3	Osteolysis 02/2010 - 01/2007
2	Bone Resorption 01/2012 - 03/2008
1	Carcinoma (Carcinomatosis) 09/2007
1	Brain Neoplasms (Brain Tumor) 09/2007
1	Neurologic Manifestations (Neurological Manifestations) 09/2007
1	Melanoma (Melanoma, Malignant) 09/2007
1	Noninfiltrating Intraductal Carcinoma (DCIS) 04/2003
1	Ductal Carcinoma 04/2003

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2004
3	Messenger RNA (mRNA)IBA 01/2018 - 07/2013
2	ChemokinesIBA 01/2018 - 01/2012
2	Complementary DNA (cDNA)IBA 01/2013 - 02/2010
2	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2012 - 03/2008
2	1-dodecylpyridoxal (PLD)IBA 10/2011 - 01/2006
2	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 10/2011 - 01/2006
2	liposomal doxorubicin (Doxil)FDA Link 10/2011 - 01/2006
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2008 - 01/2007
2	Claudin-3IBA 09/2007 - 05/2004
2	Clostridium enterotoxinIBA 09/2007 - 05/2004
2	Tight Junction ProteinsIBA 05/2004 - 04/2003
1	CarbonatesIBA 01/2018
1	Conditioned Culture MediaIBA 01/2018
1	gamma-glutamylaspartic acidIBA 01/2018
1	LigandsIBA 01/2018
1	Chemokine CCL20IBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Trans-Activators (Trans-Acting Factor)IBA 01/2018
1	Chemotactic FactorsIBA 01/2018
1	Interleukin-11 (Interleukin 11)IBA 01/2016
1	Estrogens (Estrogen)FDA Link 07/2013
1	Estrogen ReceptorsIBA 07/2013
1	diphosphoric acid (pyrophosphoric acid)IBA 01/2013
1	Carboplatin (JM8)FDA LinkGeneric 10/2011
1	Albumin-Bound Paclitaxel FDA Link 10/2011
1	Fluorouracil (Carac)FDA LinkGeneric 10/2011
1	Methotrexate (Mexate)FDA LinkGeneric 10/2011
1	CalciumIBA 03/2008
1	osteoclast stimulating factorIBA 03/2008
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2008
1	Matrix Metalloproteinases (MMPs)IBA 01/2008
1	Claudin-4IBA 09/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2007
1	ClaudinsIBA 08/2006
1	afimoxifene (hydroxytamoxifen)IBA 01/2006
1	Antineoplastic Agents (Antineoplastics)IBA 01/2006
1	DNA (Deoxyribonucleic Acid)IBA 05/2004
1	ParaffinIBA 05/2004
1	Histone Deacetylase InhibitorsIBA 05/2004
1	Cyclin D2IBA 05/2004
1	retinoic acid receptor betaIBA 05/2004
1	NucleotidesIBA 04/2003

Therapy/Procedure

7	Therapeutics 07/2013 - 05/2004
1	Neoadjuvant Therapy 01/2006